Compare Crispr Therapeutics AG (CRSP) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Home Depot Inc — how do they compare? Crispr Therapeutics AG trades at $51.64 (market cap $4.97B), while Home Depot Inc trades at $341.27 (market cap $336.77B). The key difference: Home Depot Inc is far larger — about 67.8× Crispr Therapeutics AG's market cap, and Home Depot Inc pays a 2.76% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | HD | |
|---|---|---|
Market Cap | $4.97B | $336.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $76.78 | $423.42 |
52-Week Low | $44.34 | $297.51 |
Enterprise Value | $3.32B | $398.32B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRSP trades at $50.63, down 5.1% over 24 hours, amid a bearish technical signal. The company shows deep losses with a net income margin of -56,853.4% in 2025 and negative cash flow from operations. However, analyst consensus remains optimistic with a $74.50 price target, and recent news highlights FDA approval for Casgevy, expanding its gene therapy market.
The outlook hinges on commercial execution of Casgevy and pipeline progress, offering high growth potential in gene editing. Key risks include sustained cash burn, competitive pressures, and regulatory hurdles. Despite current financial challenges, strong analyst buy ratings suggest confidence in long-term value.
Home Depot (HD) trades at $337.74, showing modest daily gains of 0.19% amid a challenging retail environment. The stock faces technical headwinds with a bearish moving average signal and RSI at neutral levels, while fundamentals reveal steady revenue growth to $159.51B in 2025 but declining profit margins. Recent earnings show mixed results with Q2 2026 expectations set at $4.71 EPS. Institutional activity remains active with both acquisitions and reductions in positions.
The investment outlook balances strong analyst support (59% buy ratings) with near-term challenges including weakening big-ticket demand and margin pressure. The consensus price target of $370.59 suggests 9.7% upside potential, but investors face risks from housing market sensitivity and competitive pressures. Long-term prospects remain supported by professional segment growth and housing tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
